Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840109 · ClinicalTrials.gov registry record
Emotional Support Messages Following a Cancer Diagnosis
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 417
- Enrollment target
NCT03840109: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT03840109 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 417 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03840109 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 417 participants
- Enrollment target
Study Summary
Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. The messages with negative statements also differ based on whether the negative statements occur at the start or end of the message. After viewing the message, participants have the opportunity to rate the effectiveness of the message, to what extent the message made them feel better, and to what extent the message affects how they view the message provider as a useful source of emotional support.
Primary Outcome
Perceptions of message effectiveness will be tested through 4 ANOVA models that will test for differences between participants who received different messages in terms of perceived message effectiveness.
Interventions
- BEHAVIORAL Questionnaire 1a
- BEHAVIORAL Questionnaire 1b
- BEHAVIORAL Questionnaire 2a
- BEHAVIORAL Questionnaire 2b
- BEHAVIORAL Questionnaire 3a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2020-11-24 |
What the finished NCT03840109 record still lists
NCT03840109 is an observational study that tracks outcomes without assigning an intervention. The registered 417 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire 1a is the first listed.
NCT03840109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03840109 about?
NCT03840109 is a clinical study titled "Emotional Support Messages Following a Cancer Diagnosis". Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. The messages with negative statements also differ based on whether the n...
What is the current status of trial NCT03840109?
This trial is currently completed. The enrollment target is 417 participants. The study started on 2019-01-30. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT03840109?
The interventions under investigation include: Questionnaire 1a (BEHAVIORAL), Questionnaire 1b (BEHAVIORAL), Questionnaire 2a (BEHAVIORAL), Questionnaire 2b (BEHAVIORAL), Questionnaire 3a (BEHAVIORAL).
Who is sponsoring clinical trial NCT03840109?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI